Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Pulmonary fibrosis induced by H5N1 viral infection in mice

Jian Qiao* email, Miaojie Zhang* email, Jianmin Bi* email, Xun Wang* email, Guangcun Deng email, Guimei He email, Zhihua Luan email, Nana Lv email, Tong Xu email and Lihong Zhao email

Department of Pathophysiology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, PR China

author email corresponding author email* Contributed equally

Respiratory Research 2009, 10:107doi:10.1186/1465-9921-10-107

Published: 12 November 2009

Abstract

Background

Inflammatory process results in lung injury that may lead to pulmonary fibrosis (PF). Here, we described PF in mice infected with H5N1 virus.

Methods

Eight-week-old BALB/c mice were inoculated intranasally with 1 × 101 MID50 of A/Chicken/Hebei/108/2002(H5N1) viruses. Lung injury/fibrosis was evaluated by observation of hydroxyproline concentrations, lung indexes, and histopathology on days 7, 14, and 30 postinoculation.

Results

H5N1-inoculated mice presented two stages of pulmonary disease over a 30-d period after infection. At acute stage, infected-mice showed typical diffuse pneumonia with inflammatory cellular infiltration, alveolar and interstitial edema and hemorrhage on day 7 postinoculation. At restoration stage, most infected-mice developed PF of different severities on day 30 postinoculation, and 18% of the survived mice underwent severe interstitial and intra-alveolar fibrosis with thickened alveolar walls, collapsed alveoli and large fibrotic areas. The dramatically elevated hydroxyproline levels in H5N1-infected mice showed deposition of collagen in lungs, and confirmed fibrosis of lungs. The dry lung-to-body weight ratio was significantly increased in infected group, which might be associated with the formation of PF in H5N1-infected mice.

Conclusion

Our findings show that H5N1-infected mice develop the typical PF during restoration period, which will contribute to the investigation of fibrogenesis and potential therapeutic intervention in human H5N1 disease.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.